Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Favorite
Like
Tweet
Print
Mengmeng Zhao, MS
Director, Statistics & Programming
Jacobio Pharma, China (People's Republic)
Poster(s):
(T1230-05-33) Integrated Evaluation of Mechanistic Population PK and Exposure-Response for Dose Justification of Glecirasib in NSCLC Patients with KRAS G12C Mutation
Tuesday, November 11, 2025
12:30 PM - 1:30 PM
CT
